In the past couple of years, the risk of overtreating patients with ductal carcinoma in situ (DCIS) with surgery and radiation has been recognized, raising the question of whether needle biopsy with surveillance could be adequate in patients with low-grade DCIS.
Research presented at the 2016 annual meeting of the American Society of Breast Surgeons, however, found recurrence rates unacceptably high in women who underwent excision alone, without radiation, suggesting that a